High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common inherited human enzyme defect. This deficiency provides some protection from clinical malaria, but it can also cause haemolysis after administration of drugs with oxidant properties. Methods: The safety of chlorprogua...
Saved in:
Main Authors: | Caterina I. Fanello, Corine Karema, Pamela Avellino, Germana Bancone, Aline Uwimana, Sue J. Lee, Umberto d'Alessandro, David Modiano |
---|---|
Other Authors: | Nuffield Department of Clinical Medicine |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/18655 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Chlorproguanil-dapsone for malaria in Africa
by: Sornchai Looareesuwan, et al.
Published: (2018) -
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the gambia
by: Dunyo S., et al.
Published: (2018) -
Artesunate-dapsone-proguanil treatment of falciparum malaria: Genotypic determinants of therapeutic response
by: Sivicha Krudsood, et al.
Published: (2018) -
Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria
by: Corine Karema, et al.
Published: (2018) -
Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand
by: P. Wilairatana, et al.
Published: (2018)